If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAvon Protection Regulatory News (AVON)

Share Price Information for Avon Protection (AVON)

Share Price is delayed by 15 minutes
Get Live Data
1,796.00    0.00 (0.00%)
Bid:
1,796.00
Ask:
1,808.00
Spread: 12.00 (0.668%)
Market Cap: £528.95m
AVON Live PriceLast checked at - London Stock Exchange

Intraday Avon Protection Share Chart

CEO Succession Update

30 Sep 2022 07:00

RNS Number : 2478B
Avon Protection PLC
30 September 2022
 

30 September 2022

Avon Protection plc

("Avon Protection" or "the Group")

CEO succession update

As set out in the announcement on 24 May 2022, Paul McDonald today steps down from his role as Chief Executive Officer (CEO). The Board is well advanced in the recruitment process for his successor, led by the Nomination Committee with the support of external consultants. In order to ensure executive continuity whilst this selection process is concluded, Bruce Thompson, currently Non-Executive Chair, will become Executive Chair, with effect from 1 October until a new CEO is in place. As a result of this change, Bruce will step down from his role on the Remuneration Committee during this period.

Bruce joined Avon Protection as Non-Executive Chair Designate in March 2020, having previously been Chief Executive Officer of Diploma PLC, the FTSE 250 specialised technical products and services business, for over twenty years.

The Board will make a further announcement regarding the appointment of a new CEO in due course.

For further enquiries, please contact:

Avon Protection

 

Bruce Thompson, Executive Chairman

+44 1225 896 848

Rich Cashin, Chief Financial Officer

 

Rory Wiltshire, Investor Relations Manager

 

 

MHP Communications

 

Andrew Jaques

+44 771 003 2657

Charlie Barker

avonprotection@mhpc.com

Pete Lambie

 

 

Note to editors:

Avon Protection designs and produces life-critical personal protection solutions for the world's militaries and first responders. With a portfolio that includes Chemical, Biological, Radiological, Nuclear ("CBRN"), respiratory and head protection products, our mission is to enhance the performance, efficiency and capability of our customers whilst providing ever increasing levels of protection.

Avon Protection operates from six sites employing approximately 1,000 people and is listed on the London Stock Exchange (LSE: AVON).

For further information, please visit our website www.avon-protection-plc.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOALLMRTMTTTBFT
Date   Source Headline
24th Sep 20207:00 amRNSAcquisition update
23rd Sep 202011:00 amRNSHolding(s) in Company
23rd Sep 20207:00 amRNSHolding(s) in Company
21st Sep 20203:00 pmRNSNotification of transaction of PDMR
16th Sep 20205:00 pmRNSHolding(s) in Company
15th Sep 202012:00 pmRNSHolding(s) in Company
15th Sep 20207:00 amRNSUpdate: Proposed Acquisition of Team Wendy
14th Sep 20207:00 amRNSApproval of milkrite | InterPuls divestment
11th Sep 202011:30 amRNSPUBLICATION OF CIRCULAR
9th Sep 20201:00 pmRNSDirectors'/PDMR Shareholdings
9th Sep 20207:00 amRNSPROPOSED ACQUISITION OF TEAM WENDY, LLC
28th Aug 20207:30 amRNSU.S. Department of Defense M61 filter contract
19th Aug 20207:00 amRNSNATO Support & Procurement Agency Contract Award
17th Aug 20203:00 pmRNSHolding(s) in Company
7th Aug 202011:00 amRNSDirector/PDMR Shareholdings
8th Jul 202011:00 amRNSDirectors'/PDMR Shareholdings
7th Jul 20202:00 pmRNSHolding(s) in Company
2nd Jul 20207:00 amRNSAgreement to divest milkrite | InterPuls
29th Jun 20207:00 amRNSU.S. Department of Defense M50 Mask System Order
24th Jun 20207:00 amRNSU.S. DoD M50 Mask System Sustainment Contract
18th Jun 202012:08 pmRNSSecond Price Monitoring Extn
18th Jun 202012:02 pmRNSPrice Monitoring Extension
5th Jun 20205:00 pmRNSDirectors'/PDMR Shareholdings
3rd Jun 20203:00 pmRNSHolding(s) in Company
20th May 20205:00 pmRNSHolding(s) in Company
19th May 20207:00 amRNSHalf-year Report
15th May 20207:01 amRNSDirector Declaration
6th May 20205:00 pmRNSHolding(s) in Company
6th May 20207:00 amRNSDirector/PDMR Shareholding
20th Apr 20207:00 amRNSNotice of Results
8th Apr 20209:00 amRNSDirectors'/PDMR Shareholdings
7th Apr 20204:41 pmRNSSecond Price Monitoring Extn
7th Apr 20204:36 pmRNSPrice Monitoring Extension
7th Apr 20204:00 pmRNSHolding(s) in Company
30th Mar 20207:00 amRNSAppointment of Non-Executive Director
26th Mar 20207:00 amRNSU.S. Defense Logistics Agency Body Armor Contract
25th Mar 202012:08 pmRNSSecond Price Monitoring Extn
25th Mar 202012:02 pmRNSPrice Monitoring Extension
25th Mar 20207:00 amRNSU.S. Defense Logistics Agency Body Armor Contract
20th Mar 20204:48 pmRNSSecond Price Monitoring Extn
20th Mar 20204:40 pmRNSPrice Monitoring Extension
19th Mar 20204:15 pmRNSDirector/PDMR Shareholding
16th Mar 20202:55 pmRNSDirector/PDMR Shareholding
12th Mar 202010:00 amRNSHolding(s) in Company
6th Mar 20205:02 pmRNSDirector/PDMR Shareholding
3rd Mar 20207:00 amRNSHolding(s) in Company
2nd Mar 20207:00 amRNSU.S. Army Body Armor Contract Award
28th Feb 20207:00 amRNSU.S. Department of Defense M69 Aircrew Mask Orders
26th Feb 20205:30 pmRNSEi Group
21st Feb 202012:00 pmRNSNotification of transaction of PDMR

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.